➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Medtronic
Moodys
Mallinckrodt
Johnson and Johnson

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Patent: 7,067,539

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,067,539
Title:Cannabinoid receptor ligands
Abstract: The invention relates to compounds of the formula ##STR00001## a prodrug thereof, or a pharmaceutically acceptable salt, solvate or stereoisomer of the compound or of said prodrug; which exhibit anti-inflammatory and immunodulatory activity. Also disclosed are pharmaceutical compositions containing said compounds and methods of using the compounds for the treatment of various diseases and conditions.
Inventor(s): Kozlowski; Joseph A. (Princeton, NJ), Shih; Neng-Yang (North Caldwell, NJ), Lavey; Brian J. (Chatham, NJ), Rizvi; Razia K. (Bloomfield, NJ), Shankar; Bandarpalle B. (Branchburg, NJ), Spitler; James M. (Westfield, NJ), Tong; Ling (Warren, NJ), Wolin; Ronald L. (San Diego, CA), Wong; Michael K. (North Brunswick, NJ)
Assignee: Schering Corporation (Kenilworth, NJ)
Application Number:10/214,897
Patent Claims:see list of patent claims

Details for Patent 7,067,539

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Bayer Healthcare Pharms BETASERON interferon beta-1b VIAL; SUBCUTANEOUS 103471 001 1993-07-23   Start Trial Schering Corporation (Kenilworth, NJ) 2021-02-08 RX Orphan search
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17   Start Trial Schering Corporation (Kenilworth, NJ) 2021-02-08 RX search
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24   Start Trial Schering Corporation (Kenilworth, NJ) 2021-02-08 RX Orphan search
Serono Inc REBIF interferon beta-1a SYRINGE 103780 001 2002-03-07   Start Trial Schering Corporation (Kenilworth, NJ) 2021-02-08 RX search
Serono Inc REBIF interferon beta-1a SYRINGE 103780 002 2002-03-07   Start Trial Schering Corporation (Kenilworth, NJ) 2021-02-08 RX search
Immunex ENBREL etanercept VIAL; SUBCUTANEOUS 103795 001 1998-11-02   Start Trial Schering Corporation (Kenilworth, NJ) 2021-02-08 RX Orphan search
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02   Start Trial Schering Corporation (Kenilworth, NJ) 2021-02-08 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Express Scripts
Boehringer Ingelheim
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.